Cancer metastasis as a non-healing wound.


Journal

British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635

Informations de publication

Date de publication:
04 2021
Historique:
received: 26 06 2020
accepted: 03 02 2021
revised: 25 01 2021
pubmed: 19 3 2021
medline: 28 9 2021
entrez: 18 3 2021
Statut: ppublish

Résumé

Most cancer deaths are caused by metastasis: recurrence of disease by disseminated tumour cells at sites distant from the primary tumour. Large numbers of disseminated tumour cells are released from the primary tumour, even during the early stages of tumour growth. However, only a minority survive as potential seeds for future metastatic outgrowths. These cells must adapt to a relatively inhospitable microenvironment, evade immune surveillance and progress from the micro- to macro-metastatic stage to generate a secondary tumour. A pervasive driver of this transition is chronic inflammatory signalling emanating from tumour cells themselves. These signals can promote migration and engagement of stem and progenitor cell function, events that are also central to a wound healing response. In this review, we revisit the concept of cancer as a non-healing wound, first introduced by Virchow in the 19th century, with a new tumour cell-intrinsic perspective on inflammation and focus on metastasis. Cellular responses to inflammation in both wound healing and metastasis are tightly regulated by crosstalk with the surrounding microenvironment. Targeting or restoring canonical responses to inflammation could represent a novel strategy to prevent the lethal spread of cancer.

Identifiants

pubmed: 33731858
doi: 10.1038/s41416-021-01309-w
pii: 10.1038/s41416-021-01309-w
pmc: PMC8076293
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1491-1502

Subventions

Organisme : NIH HHS
ID : DP5 OD026395
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA256188
Pays : United States

Références

Nature. 2015 Dec 17;528(7582):413-7
pubmed: 26649828
Cell. 2009 Jul 10;138(1):51-62
pubmed: 19576624
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
Int J Mol Sci. 2019 Mar 22;20(6):
pubmed: 30909462
Cancer Discov. 2014 Aug;4(8):879-88
pubmed: 25035124
Sci Transl Med. 2015 Apr 15;7(283):283ra52
pubmed: 25877890
Cancer Growth Metastasis. 2015 Jan 29;8:1-13
pubmed: 25674014
Inflamm Res. 2019 Jan;68(1):59-74
pubmed: 30306206
Development. 2016 Oct 15;143(20):3639-3649
pubmed: 27802133
Science. 2018 Sep 28;361(6409):
pubmed: 30262472
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14978-83
pubmed: 19706447
Nat Rev Cancer. 2007 Nov;7(11):834-46
pubmed: 17957189
Int J Mol Sci. 2017 May 11;18(5):
pubmed: 28492497
Biochem Biophys Res Commun. 2000 Feb 16;268(2):607-11
pubmed: 10679251
Cancer Res. 2015 Nov 1;75(21):4517-26
pubmed: 26329536
Biophys J. 2020 Mar 24;118(6):1243-1247
pubmed: 32087771
Cells. 2019 Apr 05;8(4):
pubmed: 30959852
PLoS One. 2013;8(2):e56399
pubmed: 23437124
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15990-5
pubmed: 21880956
Sci Immunol. 2017 Apr 28;2(10):
pubmed: 28626833
Cancer Res. 2015 Apr 15;75(8):1725-35
pubmed: 25744721
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195692
Cancer Discov. 2021 May;11(5):1212-1227
pubmed: 33372007
Am J Physiol Cell Physiol. 2020 May 1;318(5):C832-C835
pubmed: 32159362
PLoS One. 2013 Sep 09;8(9):e73341
pubmed: 24039918
Curr Stem Cell Rep. 2019 Dec;5(4):133-144
pubmed: 32587809
Chest. 2013 Jun;143(6):1750-1757
pubmed: 23732585
Front Immunol. 2017 Jun 22;8:726
pubmed: 28690613
Nat Med. 2018 Aug;24(8):1178-1191
pubmed: 29942093
Cell. 2017 Feb 9;168(4):670-691
pubmed: 28187288
Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6459-64
pubmed: 23553835
Cell. 2018 Jan 25;172(3):534-548.e19
pubmed: 29275861
J Exp Med. 2001 Mar 19;193(6):727-40
pubmed: 11257139
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Mol Syst Biol. 2015 Jul 14;11(7):819
pubmed: 26174933
Br J Cancer. 2010 Oct 12;103(8):1245-54
pubmed: 20877351
J Clin Med. 2016 Dec 26;6(1):
pubmed: 28035951
Cell Cycle. 2009 Oct 15;8(20):3267-73
pubmed: 19770594
Nature. 2015 Nov 5;527(7576):100-104
pubmed: 26479035
Adv Wound Care (New Rochelle). 2014 Jul 1;3(7):492-501
pubmed: 25032069
Am J Pathol. 2013 Apr;182(4):1055-64
pubmed: 23438473
Science. 2016 Apr 8;352(6282):175-80
pubmed: 27124451
Int J Cancer. 1996 Jul 17;67(2):275-82
pubmed: 8760599
Cell Rep. 2018 Sep 18;24(12):3353-3366.e5
pubmed: 30232014
Cell Death Dis. 2019 Sep 12;10(9):678
pubmed: 31515489
Cell. 2016 Mar 24;165(1):45-60
pubmed: 27015306
Nature. 2017 Aug 17;548(7667):297-303
pubmed: 28783718
Development. 2017 Mar 1;144(5):755-766
pubmed: 28246210
Int J Mol Sci. 2012 Nov 26;13(12):15767-83
pubmed: 23443092
Oncotarget. 2016 Jun 28;7(26):39363-39375
pubmed: 27276704
Nat Med. 2020 Feb;26(2):259-269
pubmed: 32042191
Nat Commun. 2020 Jul 16;11(1):3559
pubmed: 32678092
Cell Stem Cell. 2019 Jan 3;24(1):41-53
pubmed: 30609398
Physiol Rev. 2019 Jan 1;99(1):665-706
pubmed: 30475656
N Engl J Med. 1986 Dec 25;315(26):1650-9
pubmed: 3537791
Cell. 2018 Sep 6;174(6):1347-1360
pubmed: 30193109
Cancer Lett. 2015 Mar 28;358(2):115-123
pubmed: 25444903
Sci Transl Med. 2016 Oct 19;8(361):361ra138
pubmed: 27798263
Nat Rev Cancer. 2003 Jun;3(6):453-8
pubmed: 12778135
Aust N Z J Med. 1984 Oct;14(5 Suppl 3):731-4
pubmed: 6598039
J Pathol. 2008 Jan;214(2):199-210
pubmed: 18161745
Int J Mol Sci. 2020 Apr 30;21(9):
pubmed: 32366033
Blood. 2019 May 16;133(20):2178-2185
pubmed: 30898862
J Immunol. 2013 Mar 1;190(5):2381-90
pubmed: 23345327
Nat Cancer. 2020 Jan;1(1):28-45
pubmed: 32656539
Oncol Lett. 2018 Jul;16(1):679-686
pubmed: 29963133
F1000Res. 2016 Apr 19;5:
pubmed: 27134739
Cell. 2006 Jan 27;124(2):263-6
pubmed: 16439202
Front Immunol. 2014 Nov 25;5:587
pubmed: 25505466
Cell Res. 2007 Jan;17(1):3-14
pubmed: 17179981
Oncogene. 2020 Jan;39(2):278-292
pubmed: 31477842
Nature. 2018 Jan 25;553(7689):467-472
pubmed: 29342134
Nature. 2016 Mar 24;531(7595):513-7
pubmed: 26982733
J Immunol. 2009 Mar 15;182(6):3530-9
pubmed: 19265131
J Immunol Res. 2016;2016:4273943
pubmed: 28116316
Nat Med. 2014 Aug;20(8):822-32
pubmed: 25100528
FEBS Lett. 2012 Jul 4;586(14):1959-70
pubmed: 22710176
Sci Rep. 2019 Feb 20;9(1):2425
pubmed: 30787363
Am J Pathol. 2003 Dec;163(6):2221-32
pubmed: 14633597
Front Immunol. 2019 Dec 10;10:2876
pubmed: 31921140
Front Immunol. 2013 Jan 24;4:1
pubmed: 23355837
Nat Immunol. 2016 Jan;17(1):34-40
pubmed: 26681460
Front Immunol. 2015 May 26;6:263
pubmed: 26074923
Cancer Discov. 2020 Jan;10(1):26-39
pubmed: 31852718
Science. 2012 Jun 1;336(6085):1157-60
pubmed: 22539553
Mol Immunol. 2019 Jun;110:13-23
pubmed: 29273394
Curr Opin Immunol. 2016 Apr;39:44-51
pubmed: 26796069
Front Biosci. 1997 Jan 01;2:d12-26
pubmed: 9159205
J Biomed Sci. 2018 Mar 06;25(1):20
pubmed: 29506506
ISRN Mol Biol. 2012 Dec 24;2012:381428
pubmed: 27340590
Cell. 2017 Jul 13;170(2):352-366.e13
pubmed: 28709002
J Clin Invest. 2011 Jun;121(6):2065-73
pubmed: 21633173
Nature. 2019 Jan;565(7737):43-48
pubmed: 30559380
J Immunol. 2015 Oct 15;195(8):4010-9
pubmed: 26363055
Immunity. 2013 Feb 21;38(2):275-84
pubmed: 23333074
Curr Med Chem. 2012;19(35):6003-8
pubmed: 23016551
Int J Mol Sci. 2020 May 09;21(9):
pubmed: 32397392
Immunity. 2020 Jul 14;53(1):115-126.e5
pubmed: 32640258
Front Immunol. 2017 Mar 31;8:304
pubmed: 28408907
Front Oncol. 2018 May 17;8:166
pubmed: 29868483
Nature. 2005 Aug 25;436(7054):1186-90
pubmed: 15995699
Cancer Metastasis Rev. 2010 Jun;29(2):263-71
pubmed: 20437081
Nature. 2018 Mar 8;555(7695):251-255
pubmed: 29489752
Int J Exp Pathol. 2012 Aug;93(4):243-51
pubmed: 22774768
Annu Rev Cell Dev Biol. 2012;28:719-41
pubmed: 23057748
Regeneration (Oxf). 2018 Feb 23;5(1):3-25
pubmed: 29721324
Cancer Res. 2011 Mar 1;71(5):1858-70
pubmed: 21363922
Respir Res. 2017 Sep 5;18(1):167
pubmed: 28870231
J Immunother Cancer. 2015 Sep 15;3:43
pubmed: 26380088
Biochem Soc Trans. 2010 Feb;38(Pt 1):217-22
pubmed: 20074063
Science. 1966 Sep 30;153(3744):1615-20
pubmed: 5917072
Toxicol Sci. 2019 Apr 1;168(2):287-301
pubmed: 30590802
Front Immunol. 2011 Nov 24;2:65
pubmed: 22566854
Cell Mol Immunol. 2019 May;16(5):430-441
pubmed: 30778167
Nature. 2016 Dec 22;540(7634):552-558
pubmed: 27974799
Cancer Sci. 2010 Nov;101(11):2384-90
pubmed: 20825419
Annu Rev Immunol. 2019 Apr 26;37:349-375
pubmed: 30673536
Exp Cell Res. 2013 Dec 10;319(20):3094-103
pubmed: 23973668
Cell. 2012 Jan 20;148(1-2):349-61
pubmed: 22265420
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Cell. 2014 Oct 23;159(3):499-513
pubmed: 25417103
Cell Stress. 2019 May 23;3(6):195-207
pubmed: 31225514
J Clin Invest. 2013 Jul 1;:
pubmed: 23863628
Nat Cell Biol. 2019 Aug;21(8):1027-1040
pubmed: 31332347
Math Med Biol. 2012 Mar;29(1):49-65
pubmed: 20610469
Acta Biochim Biophys Sin (Shanghai). 2018 Jan 1;50(1):121-132
pubmed: 29190313
Nature. 2011 Dec 07;481(7379):85-9
pubmed: 22158103
Cancer Cell. 2017 Aug 14;32(2):135-154
pubmed: 28810142
Front Immunol. 2018 May 04;9:847
pubmed: 29780381
Gastroenterology. 2018 Nov;155(5):1348-1361
pubmed: 30118745
Inflamm Regen. 2016 Sep 12;36:15
pubmed: 29259688
J Immunol. 2012 Mar 1;188(5):2380-6
pubmed: 22287708
Int J Dev Biol. 2011;55(7-9):861-7
pubmed: 22161841
Physiol Rev. 2011 Oct;91(4):1281-304
pubmed: 22013212
Cell Death Discov. 2019 Jul 4;5:111
pubmed: 31285854
Matrix Biol. 2015 Sep;47:54-65
pubmed: 25960420
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945
Nature. 2015 Jul 9;523(7559):231-5
pubmed: 25970248
J Immunol Res. 2016;2016:4368101
pubmed: 28116318
Nat Med. 2011 Jun 26;17(7):867-74
pubmed: 21706029
Nat Rev Immunol. 2017 Sep;17(9):545-558
pubmed: 28580957
Genes Dev. 2018 Dec 1;32(23-24):1461-1471
pubmed: 30509948
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
Front Immunol. 2020 Sep 16;11:1749
pubmed: 33042107
Nature. 2016 Dec 22;540(7634):588-592
pubmed: 27974798

Auteurs

Matthew Deyell (M)

Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Chimie Biologie et Innovation, ESPCI Paris, Université PSL, CNRS, Paris, France.

Christopher S Garris (CS)

Rockefeller University, New York, NY, USA.

Ashley M Laughney (AM)

Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA. ashley.laughney@gmail.com.
Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA. ashley.laughney@gmail.com.
Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. ashley.laughney@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH